Searched for
RECEPTOR
Kiran Mazumdar-Shaw warns against long-term GLP-1 use, urges caution over weight-loss drugs, says 'for those who are not diabetic or clinically obese...'Nithin Kamath questions India's slow adoption of affordable GLP-1 weight-loss drugs, despite rising obesity. He points to challenges like l...- Psychology says people who can't start their day without coffee aren't addicted, they may be looking for an invisible mental shortcutWhy do some people feel they cannot function without coffee every morning? Psychology reveals that the habit may be linked to brain chemist...
- Israel smuggled Starlink systems into Iran, former PM saysFormer Israeli Prime Minister Naftali Bennett revealed he initiated smuggling Starlink receivers into Iran to aid anti-government protester...
- FIFA World Cup 2026: What is the ‘green whistle’? The device catching everyone's attentionCanadian footballer Ismaël Koné's use of the "green whistle" for pain relief during a World Cup match has sparked interest. This handheld i...
- Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...
- Cannabis-derived aroma compounds show surprising potential to relieve chronic pain in fibromyalgia and post-surgical models, shows researchResearchers from the University of Arizona have discovered that cannabis terpenes, the compounds responsible for the plant's distinct aroma...
- The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...
- India’s anti-obesity drug market sees slower growth after initial surge in generic semaglutide salesIndia's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...
- Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefitsEli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoa...
- Fed up of mosquitoes? 6 indoor plants that can reduce mosquitos in your homeMosquitoes are a persistent problem in India, but natural remedies offer a greener solution. Several indoor plants, including Lemon Balm, C...
- Johnson & Johnson prostate cancer drug reduces risk of cancer spread and death in late-stage studyThe study, which followed patients for over five years, found that those who received the regimen were nine times more likely to have lit...
- Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...
- Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
- Gene therapy for cholesterol: Initial test results cheerA new gene editing medicine, VERVE-102, offers hope for millions with heart conditions. Eli Lilly's drug showed significant reductions in b...
- Why are Indians suddenly buying more vitamins after starting Ozempic-like weight loss drugs?Demand for vitamin and nutritional supplements is surging in India. This trend follows the increased availability of semaglutide-based weig...
- Eli Lilly’s obesity drug shows up to 30% weight loss in trialEli Lilly's new obesity drug retatrutide shows remarkable results. In a major trial, patients lost up to 30% of their body weight. This onc...
- Why cold pizza tastes better the next morning, according to scienceWaking up to cold pizza isn't just a craving; science explains its appeal. Chilled pizza enhances salty flavors while mellowing sweetness, ...
- No cosmetic job with jabs, warns drug regulator CDSCOThe notice issued by the Central Drugs Standard Control Organisation (CDSCO) cites provisions of the Drugs and Cosmetics Act, 1940, and the...
- 25,000 touch sensors, no eyes, total darkness; meet the animal that hunts at the speed of neurons, and it's not the cheetahMeet the star-nosed mole, a small creature from eastern North America. Its unique star-shaped nose is a sensory marvel. This nose allows th...
- Dr Reddy's launches oral semaglutide biosimilar Obeda in IndiaDr. Reddy's Laboratories proudly presents Obeda, a groundbreaking oral semaglutide biosimilar for managing Type 2 diabetes in India. This i...
Load More
